AFT upgrades guidance following maiden US sale

Managing director Hartley Atkinson says he's confident AFT's investments will reward shareholders over the medium to long term. (Image: Supplied)

John Anthony

Fri, 16 Feb 2024

Dual-listed pharmaceutical company AFT Pharmaceuticals has lifted its profit guidance for the year to March following the first sale of its intravenous pain-relief medicine in the United States.AFT expects operating profit to range between $23 million and $25m, up on earlier guidance of $22m to $24m.US successIn a statement to the Australian securities exchange (ASX) and New Zealand stock exchange (NZX) on Friday morning, AFT said the update followed a review of January trading and news that Hikma Pharmaceuticals, the US licensee of its pain-re...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.

Already a Subscriber ? Sign in here.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].name) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Markets

Forsyth Barr shifts Turners Automotive to neutral

The company has delivered five consecutive years of record earnings.

Rebecca Howard 2:15pm

Energy

Contact secures gas deal with Greymouth

The agreement is for 7 petajoules a year.

Ian Llewellyn 12:30pm

The Quiz Free

QuiznessDesk, Friday, July 4

Take a break and try our quiz.

The Quizmaster 9:15am

Sponsored

Tough conversations ahead as cost of living drives employee requests for pay rises

Rising living costs put pressure on both workers and employers.

Moneyfit

Sponsored

Why corporate giving matters

Dave Letele and Z provide support where urgent need is overlooked.

Z Energy

More Markets

Markets

Forsyth Barr shifts Turners Automotive to neutral

The company has delivered five consecutive years of record earnings.

Rebecca Howard 2:15pm

Markets

Vital board backs Tait takeover

Vital’s board has unanimously recommended that shareholders and option holders accept a full takeover offer from Tait Communications, despite their view that it undervalues the company.In May, Vital shares rallied after it disclosed that Tait, a Christchurch-based critical commun...

Gregor Thompson 9:45am